Company intelligence / Profile preview
Provectus Biopharmaceuticals
Knoxville, Tennessee, United Statesprovectusbio.com ↗
- Ownership
- Public · PVCT
- Development stage
- Other
01
Overview
Provectus’s lead candidate PV-10 has shown promising results in early clinical trials for melanoma and other cancers. The company has demonstrated systemic immune activation in metastatic liver cancers. Preclinical data suggest oral administration of rose bengal may be effective against a range of solid tumors by downregulating WNK1 and Wnt signaling pathways. Dermatology program PH-10 targets inflammatory skin diseases with topical application[2][3][6]. Ophthalmic applications are being advanced through a subsidiary.
- Therapeutic areas
- DermatologyOphthalmologyOncology
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
Request access →03
Partnerships
University of Miami/Bascom Palmer Eye Institute/Ophthalmic Biophysics Center through VisiRose joint ventureacademic collaborations with University of Calgary for preclinical research[6][10]
04
Financials
- Market cap
- $22.5M
- Total revenue
- $0
- Enterprise value
- $24.9M
Beyond the preview
Go deeper on Provectus Biopharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Provectus Biopharmaceuticals.